Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
YD Bio Limited - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
YDES
Nasdaq
2836
www.ydesgroup.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for YD Bio Limited
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations.
- Jan 13th, 2026 8:00 am
YDES is A Biotechnology Company on the Move
- Jan 7th, 2026 3:03 am
YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development
- Jan 6th, 2026 7:00 am
YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap
- Jan 5th, 2026 7:00 am
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center
- Dec 16th, 2025 7:00 am
YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN
- Dec 9th, 2025 7:00 am
YD Bio Limited Expands OkaiDx™ Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection
- Dec 2nd, 2025 7:00 am
YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics
- Nov 24th, 2025 7:00 am
YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA‑Methylation Blood Test for Post‑Treatment Breast Cancer Monitoring
- Nov 5th, 2025 6:30 am
YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities
- Oct 10th, 2025 6:37 am
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results
- Sep 30th, 2025 3:25 pm
Breeze Holdings Acquisition (YDES) Rises 31% Over the Past Month
- Sep 10th, 2025 2:19 pm
Top Midday Gainers
- Aug 29th, 2025 11:55 am
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market
- Aug 29th, 2025 5:30 am
Scroll